In the U.S., an angioplasty costs $32,000. elsewhere? maybe $6,400.
Originally published on Dec. 27, 2019 in The New York Times: https://www.nytimes.com/2019/12/27/upshot/expensive-health-care-world-comparison.html
As politicians continue to lament the system’s expense, and more Americans struggle to pay the high and often unpredictable bills that can accompany their health problems, it’s worth looking at just how weird our prices really are relative to the rest of the world.
The International Federation of Health Plans, a group representing the CEOs of health insurers worldwide, publishes a guide every few years on the international cost for common medical services. Its newest report, on 2017 prices, came out this month. Every time, the upshot is vivid and similar: For almost everything on the list, there is a large divergence between the United States and everyone else.
Patients and insurance companies in the United States pay higher prices for medications, imaging tests, basic health visits and common operations. Those high prices make health care in the U.S. extremely expensive, and they also finance a robust and politically powerful health care industry, which means lowering prices will always be hard.
For a typical angioplasty, a procedure that opens a blocked blood vessel to the heart, the average U.S. price is $32,200, compared with $6,400 in the Netherlands, or $7,400 in Switzerland, the survey finds. A typical MRI scan costs $1,420 in the United States, but around $450 in Britain. An injection of Herceptin, an important breast cancer treatment, costs $211 in the United States, compared with $44 in South Africa. These examples aren’t outliers.
There are so few cases where the United States’ price isn’t the highest that they jump out. Cataract surgery costs more in New Zealand; Kalydeco, a new drug for cystic fibrosis, costs more in the United Arab Emirates. But for most of the studied cases, prices for services and drugs in other developed countries are less than half of those in the United States.
“It is staggering how much the United States is more expensive,” said John Hargraves, the director of data strategy at the Health Care Cost Institute, a group that aggregates claims data from several large U.S. insurance companies and provided the U.S. data to the study.
The international survey focuses on prices paid by private insurance companies; in many countries, public health programs pay less, meaning the gap in prices for many countries may be even larger if it took account of every patient. The survey doesn’t have information from every country, nor detailed prices for every medical procedure. Drug prices do not include rebates people receive after buying a medicine. But the report’s overall message is clear. Prices in the United States are higher for nearly everything — by a lot.
Researchers at Harvard conducted an exhaustive study last year of things that make health systems in developed countries different from one another. They found that the United States is distinct in a few ways. But the overwhelming finding of those researchers was that it’s this huge gap in prices, more than any other single factor — not the number of doctors’ visits or hospitalizations, not the quality of medical services, not differences in social service spending — that helps explain why the United States is such an expensive place to be sick.
Over the past decade, most of the political health policy debate has been about how to ensure broader insurance coverage for the public. (Another way the United States is unusual is in having so many residents without any form of health insurance.) But the debate among candidates for the 2020 presidential race has begun to tack slightly toward policies that will address price as well.
The single-payer plans Sens. Bernie Sanders and Elizabeth Warren have proposed would use a large government insurer to set prices for all medical services. Both campaigns assume substantial savings would result as that government system lowered prices across the board: for doctors, hospitals, medical devices, and drugs.
Even plans considered more moderate, like those from Pete Buttigieg, the South Bend, Indiana, mayor, and Michael Bloomberg, the media executive and former mayor of New York, would impose some controls on health care prices, by limiting the amount that doctors and hospitals could charge in the situations where they typically charge the most.
President Donald Trump, too, has pushed forward with an initiative to lower prices: Through an executive order and regulation, he is seeking to require health care providers to publicize the prices they have negotiated with insurance companies. The idea is to promote more competition through transparency, although researchers are divided on whether the measure will work. (He has also worked with bipartisan legislators to eliminate surprise billing, which occurs most commonly in medical emergencies at hospitals, though that effort has stalled.)
Higher prices are not new for the United States, but they have become newly salient, as more health insurance comes with high deductibles and other forms of cost-sharing that require patients to pay a larger part of the bill or even the full cost of their care. The overall upward creep of prices has also led insurance premiums to rise, taking a bite out of tax revenue, wages and corporate profits, too.
There’s also been some recent bipartisan interest in taking on drug prices specifically — although few policies have gotten very far in Congress.